Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Specialty Generic Drugs Market Insights
3.1. Specialty Generic Drugs– Industry snapshot
3.2. Specialty Generic Drugs -Ecosystem analysis
3.3. Specialty Generic Drugs market dynamics
3.3.1. Specialty Generic Drugs– Market Forces
3.3.1.1. Specialty Generic Drugs Market driver analysis
3.3.1.2. Specialty Generic Drugs Market restraint/challenges analysis
3.3.1.3. Specialty Generic Drugs Market opportunity analysis
3.3.2. Industry analysis - Porter's five force
3.3.2.1. Bargaining power of supplier
3.3.2.2. Bargaining power of buyer
3.3.2.3. Threat of substitute
3.3.2.4. Threat of new entrant
3.3.2.5. Degree of competition
3.3.3. Specialty Generic Drugs market PEST analysis, 2017
3.3.4. Value Chain Analysis
3.3.5. Specialty Generic Drugs Industry trends
3.3.6. Prevalence of specialty generic drugs 
4. Specialty Generic Drugs Market Size and Forecast by Application
4.1. Key findings
4.2. Oncology
4.2.1. Global market estimates and forecasts, 2017 – 2025
4.3. Infectious diseases
4.3.1. Global market estimates and forecasts, 2017 – 2025
4.4. Multiple Sclerosis
4.4.1. Global market estimates and forecasts, 2017 – 2025
4.5. Hepatitis C
4.5.1. Global market estimates and forecasts, 2017 – 2025
4.6. Others
4.6.1. Global market estimates and forecasts, 2017 – 2025
5. Specialty Generic Drugs Market Size and Forecast by Route of Administration
5.1. Key findings
5.2. Oral
5.2.1. Global market estimates and forecasts, 2017 – 2025
5.3. Parenteral
5.3.1. Global market estimates and forecasts, 2017 – 2025
5.4. Topical
5.4.1. Global market estimates and forecasts, 2017 – 2025
5.5. Injectable
5.5.1. Global market estimates and forecasts, 2017 – 2025
5.6. Others
5.6.1. Global market estimates and forecasts, 2017 – 2025
6. Specialty Generic Drugs Market Size and Forecast by Distribution Channel
6.1. Key findings
6.2. Retail Pharmacies
6.2.1. Global market estimates and forecasts, 2017 – 2025
6.3. Hospital Pharmacies
6.3.1. Global market estimates and forecasts, 2017 – 2025
6.4. Online Pharmacies
6.4.1. Global market estimates and forecasts, 2017 – 2025
7. Specialty Generic Drugs Market Size and Forecast by Regions
7.1. Key findings
7.2. North America
7.2.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.2.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.2.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.2.4. U.S.
7.2.4.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.2.4.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.2.4.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.2.5. Canada
7.2.5.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.2.5.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.2.5.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.3. Europe
7.3.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.3.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.3.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.3.4. Germany
7.3.4.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.3.4.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.3.4.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.3.5. UK
7.3.5.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.3.5.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.3.5.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.3.6. France
7.3.6.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.3.6.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.3.6.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.4. Asia Pacific
7.4.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.4.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.4.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.4.4. China
7.4.4.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.4.4.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.4.4.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.4.5. India
7.4.5.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.4.5.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.4.5.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.4.6. Japan
7.4.6.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.4.6.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.4.6.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.5. Latin America
7.5.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.5.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.5.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.5.4. Brazil
7.5.4.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.5.4.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.5.4.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.5.5. Mexico
7.5.5.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.5.5.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.5.5.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
7.6. Middle East & Africa
7.6.1. Specialty Generic Drugs Market by Application (USD Million), 2017 - 2025
7.6.2. Specialty Generic Drugs Market by Route of Administration (USD Million), 2017 - 2025
7.6.3. Specialty Generic Drugs Market by Distribution Channel (USD Million), 2017 - 2025
8. Company Profiles
8.1. Mylan N.V.
8.1.1. Overview
8.1.2. Financials
8.1.3. Product Type Benchmarking
8.1.4. Recent Developments
8.2. Teva Pharmaceuticals USA, Inc.
8.2.1. Overview
8.2.2. Financials
8.2.3. Product Type Benchmarking
8.2.4. Recent Developments
8.3. Sandoz International GmbH
8.3.1. Overview
8.3.2. Financials
8.3.3. Product Type Benchmarking
8.3.4. Recent Developments
8.4. Mallinckrodt, Akorn Inc.
8.4.1. Overview
8.4.2. Financials
8.4.3. Product Type Benchmarking
8.4.4. Recent Developments
8.5. Akorn Inc.
8.5.1. Overview
8.5.2. Financials
8.5.3. Product Type Benchmarking
8.5.4. Recent Developments
8.6. Valeant Pharmaceuticals International Inc.
8.6.1. Overview
8.6.2. Financials
8.6.3. Product Type Benchmarking
8.6.4. Recent Developments
8.7. Endo Pharmaceuticals Inc.
8.7.1. Overview
8.7.2. Financials
8.7.3. Product Type Benchmarking
8.7.4. Recent Developments
8.8. Pfizer Inc.
8.8.1. Overview
8.8.2. Financials
8.8.3. Product Type Benchmarking
8.8.4. Recent Developments
8.9. Sun Pharmaceutical Industries Ltd.
8.9.1. Overview
8.9.2. Financials
8.9.3. Product Type Benchmarking
8.9.4. Recent Developments
8.10. Apotex Corp.
8.10.1. Overview
8.10.2. Financials
8.10.3. Product Type Benchmarking
8.10.4. Recent Developments